The broad-spectrum cathepsin inhibitor E64d and the specific CatB inhibitor CA-074Me were both proved capable of reducing brain β-amyloid peptides and improving memory in the murine Alzheimer’s disease model[42]. This evidence concerns the gene CTSS and Alzheimer disease.